Ulla Westin (Former)
11 – 20 of 32
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Airway inflammation evaluated in a human nasal lipopolysaccharide challenge model by investigating the effect of a CXCR2 inhibitor.
(
- Contribution to journal › Article
- 2011
-
Mark
Secretory Leukocyte Protease Inhibitor inhibits neutrophil apoptosis.
(
- Contribution to journal › Article
- 2008
-
Mark
An association between Type 2 diabetes and alpha(1)-antitrypsin deficiency
(
- Contribution to journal › Article
- 2007
-
Mark
Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma
(
- Contribution to journal › Article
-
Mark
Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency.
(
- Contribution to journal › Article
- 2006
-
Mark
Secreted leukocyte protease inhibitor is present in aqueous humours from cataracts and other eye pathologies.
(
- Contribution to journal › Article
- 2005
-
Mark
Prolastin, a pharmaceutical preparation of purified human alpha 1-antitrypsin, blocks endotoxin-mediated cytokine release
(
- Contribution to journal › Article
- 2004
-
Mark
Increased plasma levels of serine proteinase inhibitors in lung cancer patients.
(
- Contribution to journal › Article
-
Mark
αl-antitrypsin and its C-terminal fragment attenuate effects of degranulated neutrophil-conditioned medium on lung cancer HCC cells, in vitro
(
- Contribution to journal › Article
- 2003
-
Mark
Human mast cells decrease SLPI levels in type II - like alveolar cell model, in vitro.
(
- Contribution to journal › Article